Company Overview of Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a drug discovery company, develops small molecule therapeutics for Alzheimer's and other neurodegenerative diseases. Its products targets the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. The company was incorporated in 2007 and is based in Pittsburgh, Pennsylvania.
2403 Sidney Street
Pittsburgh, PA 15203
Founded in 2007
Key Executives for Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Elan Holdings, Inc.||United States|
|Annovation BioPharma, Inc.||United States|
|Novalar Pharmaceuticals, Inc.||United States|
|La Belle, Inc.||United States|
|Bayer Healthcare Animal Health Inc.||United States|
Recent Private Companies Transactions
March 20, 2014
To contact Cognition Therapeutics, Inc., please visit www.cogrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.